Accession Number : ADA260145


Title :   Roundtable for the Development of Drugs and Vaccines Against Acquired Immunodeficiency Syndrome (AIDS).


Descriptive Note : Progress rept.,


Corporate Author : NATIONAL ACADEMY OF SCIENCES-NATIONAL RESEARCH COUNCIL WASHINGTON DC


Personal Author(s) : Weiss, Robin


Full Text : http://www.dtic.mil/get-tr-doc/pdf?AD=ADA260145


Report Date : NOV 1992


Pagination or Media Count : 21


Abstract : The Roundtable for the Development of Drugs and Vaccines Against AIDS, established in December 1988, is composed of leaders from government, the pharmaceutical industry, academia, and patient advocacy. Its mission is to explore impediments to the rapid availability of safe, effective drugs and vaccines for HIV infection and AIDS. The Roundtable meets quarterly and holds workshops and conferences on topics selected for their urgency and for their potential to expedite drug and vaccine development and availability, if addressed constructively. After completing its first term in December 1991, the Roundtable was renewed for another two-year term. New co-chairs and seven additional members have been appointed to serve on the Roundtable. During their approximately four-year tenure, Roundtable members have reviewed aspects of the state of scientific knowledge relevant to the design of therapeutic and preventive agents; examined some of the impediments to successful HIV drug and vaccine development, approval, and availability; and discussed strategies to promote the development of drugs and vaccines against AIDS. as a result, the Roundtable has drawn considerable attention as a forum for exploring the scientific basis of innovative policies being tested in the AIDS arena and for helping to foster increased communication among public- and private-sector representatives interested in furthering the development of effective HIV drugs and vaccines. As described below, the Roundtable's activities comprise a collection of discrete themes that are unified by their having been identified as important obstacles to successful HIV drug and vaccine development.


Descriptors :   *MEDICAL RESEARCH , *HUMAN IMMUNODEFICIENCY VIRUSES , *ACQUIRED IMMUNE DEFICIENCY SYNDROME , THERAPY , GENES , PATHOGENESIS , INFECTIOUS DISEASE TRANSMISSION , VACCINES , EPIDEMIOLOGY , IMMUNIZATION , DRUGS , ANTIVIRAL AGENTS


Subject Categories : MEDICINE AND MEDICAL RESEARCH
      PHARMACOLOGY


Distribution Statement : APPROVED FOR PUBLIC RELEASE